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approach to assess the quality of evidence of diagnostic tests. Its use in Cochrane diagnostic test accuracy reviews is new. We applied this
approach to three Cochrane reviews with the aim of better understanding the application of the GRADE criteria to such reviews.
Study Design and Setting: We selected reviews to achieve clinical and methodological diversities. At least three assessors indepen-
dently assessed each review according to the GRADE criteria of risk of bias, indirectness, imprecision, inconsistency, and publication bias.
Two teleconferences were held to share experiences.
Results: For the interpretation of the GRADE criteria, it made a difference whether assessors looked at the evidence from a patient-
important outcome perspective or from a test accuracy standpoint. GRADE criteria such as inconsistency, imprecision, and publication bias
were challenging to apply as was the assessment of comparative test accuracy reviews.
Conclusion: The perspective from which evidence is graded can influence judgments about quality. Guidance on application of
GRADE to comparative test reviews and on the GRADE criteria of inconsistency, imprecision, and publication bias will facilitate the op-
erationalization of GRADE for diagnostics.  2014 The Authors. Published by Elsevier Inc.
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Open access under C13 years developed a rigorous methodology for assessing the
quality of the evidence and grading the strength of recom-
mendations in health care [1e5]. The appeal of GRADE lies
in its ability to provide structure and transparency in the usu-
ally complex process of making evidence-based recommen-
dations. It requires a clear clinical question and outcomes
important to the patient to be defined from the outset, fol-
lowed by a structured systematic review of the available ev-
idence. The quality of the evidence is then assessed by
considering eight criteria, of which five criteria such as risk
of bias, indirectness, inconsistency, imprecision, and publi-
cation bias are used to downgrade the quality of evidence.
Three other criteria such as magnitude of the effect,
doseeresponse relation in the effect, and opposing plausible
residual bias or confounding can be used to upgrade theC BY-NC-ND license. 
761G. Gopalakrishna et al. / Journal of Clinical Epidemiology 67 (2014) 760e768What is new?
Key findings
 When defining the key question(s) for assessing the
quality of evidence, a clear distinction is needed
between test accuracy and patient-important out-
come(s) as the choice outcome. Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) criteria such as ‘‘inconsis-
tency,’’ ‘‘imprecision,’’ and ‘‘publication bias’’
were challenging to interpret and apply as was
the application of the criteria to comparative test
accuracy evidence.
What this adds to what was known?
 The current publications on the GRADE for diag-
nostics approach present an explanation of the
approach. In contrast, this article describes the
‘‘practical’’ application of the approach when used
to rate a body of evidence such as diagnostic tests
accuracy review. It outlines a number of real-life
challenges and considerations a user of this
approach may encounter and provides suggestions
on how these can be addressed.
What is the implication and what should change
now?
 Explicit guidance and worked examples illustrating
the application of the GRADE criteria of inconsis-
tency, imprecision, and publication bias would facil-
itate the use of the methodology when rating
diagnostic test accuracy evidence. Guidance on the
translation of a Quality Assessment of Diagnostic
Accuracy Studies (QUADAS) 2 risk of bias and
applicability assessment to the corresponding
GRADE criteria of risk of bias and indirectness
would help users in the use of the GRADE approach.
quality of the evidence (Fig. 1). To come to a recommenda-
tion based on the available body of evidence, its quality, as-
sessed according to these eight GRADE criteria, is then
considered in the context of benefits vs. harms of the test
or intervention in question, patients’ values and prefer-
ences, and resource implications.
Although the GRADE methodology is developed as a
generic tool that can be used to assess the quality of evi-
dence for different health care questions, it has most exten-
sively been used for grading the quality of evidence and
strength of recommendations for therapeutic questions
[3,6,7] and to a lesser degree in the area of medical testing
[8e13]. The GRADE approach to grading evidence about
the use of medical tests emphasizes the importance of mak-
ing decisions based on the impact on patient outcomes. Itsuggests that specific PICO-styled questions about medical
tests should specify patients for whom the diagnostic
testing is being considered (P), the index test or diagnostic
strategy (I), the comparator test or testing strategy (C), and
the patient-important outcomes (O) related to the use of the
test in question. In this approach, the patient-important out-
comes are defined as the desirable and undesirable conse-
quences related to patients being correctly or incorrectly
classified as having or not having a given condition, that
is, into one of the four test accuracy categories: true posi-
tives (TPs), true negatives (TNs), false negatives (FNs),
and false positives (FPs). As such, diagnostic test accuracy
is considered a surrogate outcome to patient-important out-
comes such as morbidity, mortality, or quality of life mea-
sures. [9,14,15]. As the evidence base of diagnostic tests is
usually restricted to studies that do not measure patient-
important outcomes directly, the GRADE for diagnostic
approach specifies the need for a clinical judgment making
step to link test accuracy to health outcomes.
Research around the conduct and evaluation of test accu-
racy evidence is increasing [16e18]. However, research
evaluating the direct impact of tests on patient outcomes re-
mains sparse for a number of documented reasons [19].
This implies that decision makers often need to consider
the potential impact of tests on patient outcomes based
solely on the test accuracy evidence. This, together with
the increasing uptake of GRADE as a preferred method
of evidence appraisal [6], prompted our interest to docu-
ment issues and challenges a systematic reviewer or guide-
line panel might counter when applying the GRADE
criteria to appraise evidence on test accuracy. We were
especially interested in applying the GRADE criteria to
evaluate Cochrane diagnostic tests accuracy reviews as both
the GRADE Working Group and the Cochrane Collabora-
tion are beginning to work closely together to align the re-
porting and evaluation of test accuracy evidence.
We focused on the application of those GRADE criteria
for which published guidance is currently available. These
are the five criteria for downgrading the quality of evi-
dence. We felt that there was not sufficient guidance avail-
able yet on the application of the other three GRADE
criteria for upgrading evidence related to tests (Fig. 1).
The GRADE Working Group is currently preparing two
additional publications, which present how the concept of
the GRADE approach can be applied to rating the quality
of diagnostic test accuracy evidence. Our study is a quali-
tative evaluation of using the approach in practice, based
on current published guidance. It is relevant and useful to
ongoing users who need to continue to appraise diagnostic
test accuracy evidence based on GRADE for diagnostics
guidance that is available in the literature at present.2. Methods
We assessed the quality of the evidence synthesized in
three Cochrane diagnostic test accuracy reviews [20e22].
Fig. 1. An overview of GRADE criteria for rating a body of evidence and developing recommendations. GRADE, Grading of Recommendations
Assessment, Development and Evaluation.
762 G. Gopalakrishna et al. / Journal of Clinical Epidemiology 67 (2014) 760e768At the time of the conduct of this study between January
and March 2012, there were a total of eight published test
accuracy reviews in the Cochrane Library. The field of
diagnostic test accuracy review is a relatively new and
rapidly evolving field in which the first Cochrane diagnostic
test accuracy review appeared just 5 years ago. With this in
mind, we made a purposeful selection of reviews that were
more recently published while trying to achieve diversity in
clinical areas and methodological issues from what was
available in the Cochrane Library at that time.
Table 1 provides a brief description of each of the three
selected reviews. None of the reviews used the GRADE
methodology to evaluate the evidence. All the three reviews
used the original Quality Assessment of Diagnostic Accu-
racy Studies (QUADAS) instrument to assess the included
diagnostic accuracy studies [23]. We did not perform any
additional formal quality appraisal of each review.
For the review by Abba et al. [22], we chose to evaluate
the evidence for the two most frequently reported rapid
diagnostic tests (Paracheck and ParaSight). Although the
two tests were not directly evaluated against one another
in any of the studies included in the review, we decided
to rate the quality of the evidence for these two tests as a
comparative test accuracy review.
A convenience sample of eight assessors with expertise
in the GRADE methodology and/or diagnostic test accu-
racy reviews were invited to participate in this study. The
assessors chosen had varying levels of expertise in the
GRADE methodology ranging from proficient to less expe-
rienced GRADE users. A protocol was developed and
distributed among the assessors. It outlined the publications
on GRADE for diagnostics to be used as guidance when
applying the GRADE criteria [9,14,15] and a template of
a GRADE ‘‘evidence profile’’ which assessors could use.
At least three assessors independently rated each reviewaccording to the five GRADE criteria for downgrading
quality of evidence [14] (Table 1).
Assessors were instructed to explain each judgment that
they made about the quality of the evidence and to docu-
ment all considerations. Two teleconferences were held to
share experiences and discuss the challenges encountered.
The focus of the discussions was to document how asses-
sors interpreted the GRADE criteria, the issues faced in do-
ing so, and the rationales used to rate the GRADE criteria.
We did not record whether assessors downgraded the evi-
dence for each criteria by 1 or 2 points as per the GRADE
methodology for downgrading [15].
One author (G.G.) collated all comments discussed dur-
ing the teleconferences and individual evidence profiles
created by each assessor. These were grouped into different
categories, based on content, and circulated among all asses-
sors for validation. Differences were discussed among all
assessors.3. Results
The issues encountered could be grouped into four cate-
gories: question formulation, each of the five GRADE
criteria for downgrading evidence, issues applicable across
all GRADE criteria, and issues related to the comparative
test accuracy review (Table 2).
3.1. Question formulation
Six of the eight assessors felt that guidance on the
formulation of questions for test accuracy reviews was
not explicit enough in the GRADE for diagnostics
approach. Across all three systematic reviews, assessors
formulated different types of key questions; sometimes,
no key question was present. For instance, in the review
Table 1. Description of reviews and distribution of assessors across the three Cochrane reviews
Cochrane diagnostic
test accuracy review Description of review Number of assessors
Optical coherence tomography
(OCT) for detection of macular
edema in patients with diabetic
retinopathy
This review assessed the diagnostic accuracy of OCT for the detection of
diabetic macular edema and/or its more severe form of clinically
significant macular edema.
The review included nine cohort studies.
Unit of analyses in the included studies was the individual eye and not the
patient.
3 (R.A.M., M.W.L., and
M.M.G.L.)
Physical examination for lumbar
radiculopathy due to disc
herniation in patients with low
back pain.
This review assessed tests performed during physical examination (alone or
in combination) to identify radiculopathy due to lower lumbar disc
herniation as established during imaging or surgery in patients with low
back pain and sciatica.
The review included 19 studies (16 cohort studies and 3 caseecontrol
studies), of which 1 study was conducted in a primary care setting.
A variety of physical examination tests were used in the studies with the
straight leg raising test or Lasegue test being the most frequent (15
studies). The included studies used different reference standards, with
surgical findings or imaging (CT or MRI) being the most frequent ones
(nine and six studies, respectively).
6 (G.G., R.A.M., M.W.L.,
C.D., C.H., and R.J.P.M.S.)
Rapid diagnostic tests (RDTs) for
diagnosing uncomplicated
Plasmodium falciparum malaria
in endemic countries.
This review assessed the diagnostic accuracy of immunochromatography-
based RDTs for detecting clinical P. falciparum malaria (symptoms
suggestive of malaria plus P. falciparum parasitaemia detectable by
microscopy) in persons living in malaria endemic areas who present to
ambulatory health care facilities with symptoms of malaria and to
identify which types and brands of commercial test best detect clinical P.
falciparum malaria.
The authors included 111 test evaluations from a total of 74 studies, of
which 104 test evaluations were in comparison with microscopy, 2 test
evaluations were in comparison with PCR-adjusted microscopy, and 5
studies compared RDTs with PCR only.
All studies were consecutive patient series.
6 (G.G., R.A.M., J.B., M.W.L.,
M.M.G.L., and C.D.)
Abbreviations: CT, computed tomography; MRI, magnetic resonance imaging; PCR, polymerase chain reaction.
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contained different elements. The question of one assessor
explicitly included a patient-important outcome and the
place of the index test in the testetreatment pathway. The
second assessor’s question was centered on test accuracy
and did not contain any patient-important outcomes,
although it did explicitly define the place of the index test
in the testetreatment pathway. The third assessor’s ques-
tion had no other elements defined except for the index
and the reference tests.
3.2. Issues in applying GRADE criteria in a single test
review
3.2.1. Risk of bias
In all three reviews, the methodological quality of the
primary studies was assessed with the QUADAS tool
[23]. The QUADAS results were used to judge the GRADE
criterion risk of bias. Assessors found it difficult to make
judgments on the quality of the evidence when a QUADAS
item was reported as ‘‘unclear.’’ This was resolved through
discussion among the assessors on the importance of such
an item on the overall impact on the quality of the evidence.
Assessors also found it difficult to make an overall judg-
ment on the extent of bias for the corresponding GRADE
criterion as they struggled on how to assess the differentitems in the QUADAS check list to make a final summary
statement on the risk of bias for the overall body of
evidence.
3.2.2. Indirectness
Assessors reported two observations with the GRADE
criterion ‘‘indirectness.’’ First, the perspective from which
the assessor was looking at the evidence quality
influenced the judgment on indirectness. If an assessor
was assessing the evidence with patient outcomes as the
objective for rating the evidence, the evidence was down-
graded by virtue of the fact that evidence relating to test ac-
curacy is indirect evidence for patient-important outcomes.
Assessors who assessed the quality of the evidence with
test accuracy as the end outcome, however, focused on as-
sessing the extent of indirectness to the intended testing
setting among the included studies. The indirectness of
the evidence to patient-important outcomes was not
considered an issue by these assessors.
Second, some assessors downgraded the quality of the
evidence for indirect comparisons if a patient population
had been studied that did not match the spectrum of the
population for the intended application of the index test.
For instance, the aim of the review by Van der Windt
et al. [21] was to assess the accuracy of the index test
Table 2. Summary of main issues in the application of the GRADE domains across three Cochrane diagnostic test accuracy reviews
Key issues identified Observations
Key question formulation Key question formulation was not an explicit step; guidance on how these could be defined was also not explicit
Assessors whose key questions focused on outcomes that were patient important made different judgments on
evidence quality compared with assessors whose key questions focused on test accuracy as the outcome
GRADE domains
Risk of bias (RoB) Assessors were unclear on how to judge QUADAS items labeled ‘‘unclear’’
Indirectness (1) Issues on applicability of findings to patient population of interesta
(2) Test accuracy is inherently indirect evidence for patient outcomes, resulting in default downgrading of the
quality
Inconsistency Assessors used different rationales for downgrading (eg, confidence interval overlap, unexplained heterogeneity,
inconsistent use of test threshold positivity, and variable reference standard definitions)
Imprecision Assessors used different rationales for downgrading (eg, small study numbers, wide confidence intervals)
Publication bias Assessors were unclear on how to assess this
Across all GRADE domains Reviewers had to be conscious to not double downgrade on a single factor
Additional points for
comparative test reviewb
(1) For an indirect comparison of two index tests, the quality of the assessment of test accuracy for each test needed
to be assessed first and then the quality of the comparison
(2) When making the relative comparison, the score for each GRADE domain (eg, RoB, indirectness, etc.) was
determined as the lower of the two scores for that domain for each index test compared with its reference
standard
(3) The overall quality of evidence (for an indirect comparison of two index tests) was further downgraded by one
level for indirectness
Abbreviations: GRADE, Grading of Recommendations Assessment, Development and Evaluation; QUADAS, Quality Assessment of Diagnostic
Accuracy Studies.
a Physical examination for lumbar radiculopathy due to disc herniation in patients with low-back pain (Review) [21].
b Rapid diagnostic tests for diagnosing uncomplicated P.falciparum malaria in endemic countries (Review) [22].
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combination) in the primary care setting. Eight of nine
studies in this review, however, were performed in a sec-
ondary or tertiary care setting. Hence, the evidence was
downgraded for indirectness.
3.2.3. Inconsistency
The two main rational used to downgrade the evidence
for this criterion were based on the presence of unexplained
heterogeneity among studies and/or the degree of overlap in
the confidence intervals (CIs) of the accuracy estimates. If
the results of the studies were in the same direction with
overlapping CIs, inconsistency was deemed unlikely.
3.2.4. Imprecision
In the review by Virgili et al., the unit of analysis was
not the individual subject but the individual eye, which
made it challenging to rate the GRADE criterion of impre-
cision. CIs based on number of eyes tested could give a
false sense of a more precise estimate in comparison with
an estimate based on the number of subjects tested.
Generally, assessors found it difficult to define how wide
a CI should be before it was considered imprecise. Without
clinical expertise on the topic of the review or in the
absence of guidance in the review itself, assessors tended
to downgrade the evidence for imprecision based on indi-
vidual judgment. In the review by Virgili et al., the 95%
CI for specificity was reported as 0.74e0.92 and that for
sensitivity as 0.74e0.84. Although all three assessors felt
that the CI for specificity represented a wide CI and shouldbe downgraded, the CI for the sensitivity estimate resulted
in conflicting views: two assessors felt that the sensitivity
estimate did not have a wide CI and did not downgrade
the evidence, whereas the third assessor was unsure. One
assessor worked out the projected range of subjects for each
of the four test accuracy categories (TP, FN, TN, and FP)
for a given prevalence of the target condition in question.
From there, the assessor made a judgment on imprecision
based on the projected numbers for FN and FP derived from
this calculation.3.2.5. Publication bias
Assessors unanimously agreed that guidance was needed
on how to appraise test accuracy evidence for publication
bias: Seven of the eight assessors did not score the evidence
for this criterion because they felt that they had insufficient
guidance on its application [24]. One assessor made a judg-
ment based on the assessor’s own interpretation of the thor-
oughness of the search methodology, in terms of databases
searched, whether filters had been used, and if grey litera-
ture was included.3.2.6. General comments
In a number of instances, assessors had to be cautious to
not double downgrade the evidence for more than one
GRADE criterion. For instance, on the issue of representa-
tiveness of patient populations, assessors had to be
conscious to not downgrade the evidence twice for criteria
‘‘risk of bias’’ and ‘‘indirectness.’’
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comparative test review
The review by Abba et al. [22] did not contain any studies
that compared both the index tests of interest (ie, Paracheck
and Parasight) directly to one another. As a result, assessors
felt that they had to make an indirect comparison of the two
tests, which raised three observations in the group. Four of
the six assessors rated the quality of the evidence for both
the index tests separately before proceeding to rate the qual-
ity of the evidence for the indirect comparison which was
based on the lower of two scores for that same criterion for
each index test. Assessors unanimously agreed that the over-
all quality of evidence for an indirect comparison of two in-
dex tests should be further downgraded an additional level
because the comparison was not a direct one.4. Discussion
4.1. Summary of results
When defining the key question(s) for assessing the
quality of evidence, a clear distinction is needed between
test accuracy and patient-important outcome(s) as the
choice outcome. GRADE criteria such as inconsistency,
imprecision, and publication bias were challenging to inter-
pret and apply as was the application of the criteria to
comparative test accuracy evidence. Appendix (www.
jclinepi.com) provides a summary comparison of similar-
ities and differences between the GRADE for interventions
and GRADE for diagnostics approaches.
4.2. Areas for further development in the GRADE for
diagnostics approach
Most assessors felt that the development of key ques-
tions and their elements were not defined explicitly enough
in the available GRADE for diagnostics guidance. A reason
for this maybe that the ‘‘PICO’’ question formulation sug-
gested as guidance for the development of a diagnostic key
question may not be directly applicable [25]. Huang et al.
demonstrated this when they analyzed 59 real-world clin-
ical questions and showed that one of the limitations of
the direct application of the PICO to formulating diagnostic
questions was the absence of a clear distinction between
population and disease, both elements of which can influ-
ence the accuracy of a test.
The other issue our study highlighted was that a clear
distinction is needed between test accuracy and patient-
important outcome(s) as the outcome included impacts
judgments about evidence quality. Guidance would be help-
ful on developing key questions that are applicable to both
types of outcome.
The operationalization of the criteria inconsistency, impre-
cision, and publication bias would be better facilitated with
worked examples as have been provided by the GRADE
Working Group for intervention research [26e30]. Suchexamples will be a part of the next publications on the
GRADE for diagnostics approach. In our study, assessors
used their own knowledge and discussion among the group
to rate the evidence from the reviews for these three criteria.
The application of the GRADE criterion inconsistency in
intervention evidence states explicitly that unexplained het-
erogeneity in studies is a clear reason for downgrading.
Exploring sources of heterogeneity is often problematic in test
accuracy reviews because of small study numbers and poor
reporting of included studies [21]. The lack of appropriate
statistical methods for assessing study heterogeneity
in diagnostic studies further complicates this issue [31]
(Appendix at www.jclinepi.com). This means that evidence
on tests will often be downgraded for this criterion.
Assessors dealt with rating the evidence quality for
imprecision by making judgments on how wide they felt
that the CI was for the test accuracy measures of sensitivity
and specificity. One assessor’s method of calculating the
projected range of subjects that would be classified into
each of the four accuracy categories may be one way of
providing an empirical basis for making judgments on this
criterion. Such an approach puts into perspective the pro-
jected range of patients that would test as TP, TN, FP,
and FN for a given prevalence of the target condition, hence
giving an indication of the impact of a test’s accuracy in a
specific population.
Consider a test whose 95% CI for sensitivity is 50e90%.
If the prevalence of the disease is 1% that means the 95%
CI of the absolute number of patients diagnosed as TPs
works out to be between 5 and 9 for every 1,000 patients
tested. The number of patients falsely diagnosed as ‘‘not’’
having the disease (FN) will be between 1 and 5 per
1,000 patients tested. One would agree that the 95% CI
for TP and FN do not appear to be very large or in this case
imprecise at this specified pretest probability.
Now, consider the same test with the same 95% CI range
for sensitivity but with a pretest probability of 20%. This
now means that 100e180 patients will be correctly diag-
nosed every 1,000 tested (TP), whereas anything between
20 and 100 patients maybe misdiagnosed as not having
the disease (FN). This example illustrates one way in which
judgments on imprecision can be made.
This issue of how the GRADE criterion imprecision
should be judged is also encountered in intervention research
where the same considerations are faced on whether to use
relative risk, risk difference, or number needed to treat as
the measurement on which imprecision should be judged.
Publication bias was the last criterion that assessors in
this study found challenging to apply. This is not unique
to diagnostic test evidence as indicated in recent GRADE
publications [28]. The lack of consensus methods for as-
sessing publication bias for test accuracy reviews is an
added complication to this issue. Furthermore, unlike the
increasing awareness and compliance around registration
of trials [32] that allow for a way of tracking publication
bias, the lack of any kind of a registry for test accuracy
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issue of assessing publication bias in test accuracy reviews.4.3. Considerations for authors of primary studies and
systematic reviews of diagnostic test accuracy
As tests are hardly ever conducted in isolation but as part
of a testetreatment strategy, it may be helpful for authors
conducting primary test accuracy studies and authors of test
accuracy reviews to consider defining the testetreatment
pathway of the tests being evaluated in their research. This
could eventually help not only in selecting appropriate in-
dexereference tests for comparisons but also in defining
focused clinical research questions whose findings can have
meaningful impact in clinical practice and policy.
This issue was particularly highlighted in the review by
van der Windt et al. [21]. In eight of the nine studies in this
review, the index test (physical examinations done singu-
larly or in combination) was compared with reference stan-
dards (magnetic resonance imaging and surgery) that were
relevant to a different patient population and care setting
than that of the index test. This resulted in comparisons
of test accuracy between different study populations that
limited applicability of review findings to primary care
where the index test is most commonly used, and therefore,
where such evidence synthesis is likely to have the most
impact on clinical practice and policy. Van der Windt
et al. mention the need for future primary studies to be
drawn from the same population in which the index and
reference tests would be applied in practice and identify
the need for defining a ‘‘diagnostic algorithm.’’
This leads us to suggest that the definition of a testetreat-
ment pathway in both diagnostic test accuracy studies and in
test accuracy reviews could be ameaningful addition to ensure
that we ask clinically relevant questions and design equally
relevant studies to answer these questions [33]. Although the
CochraneCollaboration now requires themandatory inclusion
of a clinical pathway in all Cochrane diagnostic test accuracy
reviews, there is no explicit guidance on how this should be
done or what elements such a pathway should contain.
Several assessors struggled with rating the evidence
when the QUADAS [17,23] items were scored as unclear
by the review author. The introduction of the QUADAS-2
tool [17] could help address this concern as it calls for users
to provide judgments based on the relative importance of
individual scoring questions. QUADAS-2 requires an over-
all risk of bias judgment to be made and separately assesses
the applicability of each QUADAS criteria.
Both QUADAS-2 and GRADE for diagnostics are meth-
odological quality assessment tools gaining increasing
usage [34]. Although each is meant for a different purpose,
QUADAS for the methodological assessment of a diag-
nostic accuracy study and GRADE for diagnostics, for
the evaluation of an aggregated body of evidence, both
tools address applicability of the evidence: GRADE as part
of its indirectness criterion and QUADAS-2 as part of itsfirst three domains relating to patient selection, index test,
and reference standard. Users of both the tools may find
it useful to have guidance on how to translate applicability
judgments made using the QUADAS-2 tool to judgments
about indirectness for GRADE.
Readers of this study should note that the format pre-
sented in this study (Table 3) is a work in progress. The
GRADE Working Group and the Cochrane Diagnostic Test
Accuracy Methods Group are currently collaborating to
provide authors of future test accuracy reviews with specific
guidance on the format and type of tables to be included in
a Cochrane diagnostic test accuracy review.4.4. Other considerations
Consideration of the test’s usefulness, its clinical utility,
and the effects on patient outcomes are increasingly acknowl-
edged as being guiding factors when making guidelines for
medical tests [35,36]. However, this remains a challenge in
medical test guideline development, in which the majority of
the evidence base is in the form of accuracy studies.
This raised the issue among the assessors of this study as
to whether the indirectness of accuracy studies on patient
outcomes warrants a downgrading of the evidence by
default. The consequence of this default position would be
that the quality of the evidence from test accuracy studies
would always be considered of low quality by virtue of the
fact that it is indirect evidence for patient outcomes. Users
of the GRADE for diagnostics approach may therefore al-
ways have only low-quality evidence as long as the type
of evidence available on tests is restricted to evidence on test
accuracy. However, default downgrading of test accuracy ev-
idence on the basis of indirectness to patient outcomes may
not necessarily always be justified. Consider a scenario
involving the evaluation of a replacement test shown to have
the same or superior accuracy than its comparator test for the
diagnosis of a particular condition. In such a scenario, the
link to patient outcomes becomes less of an issue and one
can accept test accuracy evidence alone as being sufficient
without the need for downgrading for indirectness.
Given the challenges assessors in this study found in the
interpretation and application of certain GRADE criteriad
particularly, those of imprecision, inconsistency and publi-
cation biasdguideline development groups which include
more than one test accuracy review or involve more than
one review team, may find it useful to discuss in advance
the application of these criteria so a consistent approach
can be applied throughout.4.5. Limitations of this study
Some of the difficulties faced by this group when making
judgments on clinically related issues may not have occurred
if topic-specific clinical experts were involved. For instance,
assessors found it difficult to determine a clinically relevant
sensitivity and specificity value. This made it challenging for
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767G. Gopalakrishna et al. / Journal of Clinical Epidemiology 67 (2014) 760e768the assessors to define clinically acceptable sensitivity and
specificity thresholds. The involvement of a topic-specific
clinical expert would have aided in understanding the
impact of the downstream consequences of FNs and FPs,
thereby helping to make judgments on which would be
the more critical accuracy measures to focus on and what
would be acceptable thresholds for FNs and FP numbers.
The reviews chosen for this study were Cochrane diag-
nostic reviews. Given the generally rigorous methodology
of Cochrane reviews, it is likely that additional issues
could have arisen if non-Cochrane diagnostic test reviews
were included.
We acknowledge that the problems we faced in the key
question formulation might be due in part to the fact that
we had not provided a specific question for assessors to
base their evidence evaluation upon at the start. In a
real-world situation, it is likely that a systematic reviewer
or guideline developer would have a specific question
developed on which they would base their evidence
appraisal. That said, we still believe that there is a need
to review the applicability of the PICO approach and pro-
vide specific guidance on the development of key ques-
tions related to medical test evaluation.
5. Conclusions
This study shows that the application of the GRADE
criteria for appraising evidence on tests accuracy needs
further development before it can be widely applied. An
explicit systematic approach to defining the key question,
including the testetreatment pathway, and clear guidance
for the application of the GRADE criteria of inconsistency,
imprecision, and publication bias are needed.
Given the increasing use of the GRADE approach [6]
and growing collaboration between GRADE and Co-
chrane, it maybe useful for future authors of Cochrane test
accuracy reviews to consider applying GRADE to their ev-
idence appraisal, particularly on issues related to impreci-
sion, inconsistency, and publication bias which are
currently variably addressed by review authors. A more
consistent and transparent approach in evaluating test ac-
curacy evidence would help bring better clarity and consis-
tency to such systematic reviews of diagnostic test
accuracy which ultimately would also better guide deci-
sion makers on to the prudent appraisal of such evidence.
Appendix
Supplementary data
Supplementary data related to this article can be found
at http://dx.doi.org/10.1016/j.jclinepi.2014.01.006.
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